x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- Ishikane, MasahiroRemove Ishikane, Masahiro filter
- COVID-19Remove COVID-19 filter
Publication Date
Please choose a date range between 2020 and 2022.
Author
- Ohmagari, Norio4
- Ujiie, Mugen2
- Asai, Yusuke1
- Inada, Makoto1
- Ishizaka, Yukihito1
- Iwamoto, Noriko1
- Katano, Harutaka1
- Koizumi, Ryuji1
- Kusama, Yoshiki1
- Kutsuna, Satoshi1
- Maeda, Kenji1
- Maruki, Taketomo1
- Matsunaga, Akihiro1
- Mitsuya, Hiroaki1
- Morioka, Shinichiro1
- Nakamoto, Takato1
- Ono, Akane1
- Sasaki, Ryo1
- Suzuki, Tetsuya1
- Terada, Mari1
- Tsuzuki, Shinya1
Coronavirus (COVID-19) Collection
4 Results
- Case ReportOpen Access
Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection
International Journal of Infectious DiseasesVol. 119p18–20Published online: March 16, 2022- Makoto Inada
- Masahiro Ishikane
- Mari Terada
- Akihiro Matsunaga
- Kenji Maeda
- Noriko Iwamoto
- and others
Cited in Scopus: 0Since December 2019, COVID-19 caused by SARS-CoV-2 has spread worldwide (Hayakawa et al., 2020). As of January 25th, 2022, 544 re-infected COVID-19 cases have been reported worldwide (BNO news. 2022; Inada et al., 2021). - PerspectivesOpen Access
Antimicrobial Use Fell Substantially in Japan in 2020—The COVID-19 Pandemic May Have Played a Role
International Journal of Infectious DiseasesVol. 119p13–17Published online: March 16, 2022- Akane Ono
- Ryuji Koizumi
- Shinya Tsuzuki
- Yusuke Asai
- Masahiro Ishikane
- Yoshiki Kusama
- and others
Cited in Scopus: 1The COVID-19 outbreak in China at the end of 2019 had spread to Japan by early 2020. The surge in infected cases may have precipitated behavioral changes among physicians and patients, including increased unnecessary antimicrobial use (AU) that could promote antimicrobial resistance (AMR). - Case ReportOpen Access
A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient
International Journal of Infectious DiseasesVol. 113p55–57Published online: September 26, 2021- Taketomo Maruki
- Masahiro Ishikane
- Tetsuya Suzuki
- Mugen Ujiie
- Harutaka Katano
- Norio Ohmagari
Cited in Scopus: 8Since December 2019, COVID-19, caused by SARS-CoV-2 infection, has been a major health threat worldwide (Hayakawa et al., 2020). The mRNA-based BNT162b2 mRNA COVID-19 vaccine has demonstrated a high efficacy rate with an acceptable safety profile (Polack et al., 2020). In Japan, a nationwide mass BNT162b2 mRNA vaccination campaign was launched and rolled out at an exceptionally rapid pace with high vaccine acceptance. As of June 13, 2021, 14.0% (n=17 580 587) and 4.9% (n=6 104 732) of the population had received their first and second vaccine dose, respectively (Ministry of Health, Labour and Welfare, Japan, 2021). - Medical ImageryOpen Access
Periungual desquamation in a Japanese Adult recovering from severe COVID-19
International Journal of Infectious DiseasesVol. 102p37–39Published online: October 16, 2020- Takato Nakamoto
- Masahiro Ishikane
- Ryo Sasaki
- Norio Ohmagari
Cited in Scopus: 1A 50-year-old Japanese man was admitted to our hospital with a 14-day history of fever and sudden dyspnea. The patient was diagnosed with severe coronavirus disease (COVID-19) based on positive test results of RNA polymerase chain reaction for severe acute respiratory syndrome coronavirus. He was started on mechanical ventilation and extracorporeal membrane oxygenation (ECMO). He received ECMO for 23 days and was tracheostomized on hospital day (HD) 37. His general condition improved by HD 54. On HD 61, periungual desquamation appeared on the fingers of left hand (Panel 1A), left palm (Panel 1B), and both feet (Panel 1C).